trending Market Intelligence /marketintelligence/en/news-insights/trending/krqv_mdnxnur-oac2frm_q2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Lilly's animal health unit prices $2B debt offering


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


COVID-19 Impact & Recovery: Investment Banking

Lilly's animal health unit prices $2B debt offering

Eli Lilly and Co.'s Elanco Animal Health Inc. unit is looking to raise $2 billion in a debt offering.

Elanco, which recently filed for an IPO, is offering $500 million worth of 3.912% senior notes due Aug. 27, 2021; $750 million worth of 4.272% senior notes due Aug. 28, 2023; and $750 million worth of 4.90% senior notes due Aug. 28, 2028.

The transaction is expected to close Aug. 28, subject to customary closing conditions.

Earlier this year, Lilly said it was spinning off its animal health unit via an IPO following a strategic review of the business that started in late 2017.

The Indianapolis-based maker of diabetes medicines said it will focus on its pharmaceutical business instead.